Adam Wohlleben
About Adam Wohlleben
Adam Wohlleben is an Oncology Account Manager currently employed at Mirati Therapeutics in San Diego, California. He has extensive experience in oncology and immunology, having held various positions at notable companies such as Seagen, Genentech, and Pfizer Pharmaceuticals.
Current Role at Mirati Therapeutics
Adam Wohlleben serves as an Oncology Account Manager at Mirati Therapeutics, a position he has held since 2022. He operates from San Diego, California, where he is responsible for managing oncology accounts and driving business strategies in the oncology sector. His role involves collaborating with healthcare professionals and stakeholders to enhance the understanding and utilization of Mirati's oncology products.
Previous Experience at Seagen
Prior to his current role, Wohlleben worked at Seagen as a Senior Oncology Account Manager from 2019 to 2022. During his tenure in Bothell, Washington, he focused on developing and maintaining relationships with oncology healthcare providers, ensuring that they were informed about Seagen's product offerings and advancements in oncology treatments.
Experience at Genentech
Wohlleben has extensive experience at Genentech, where he held multiple roles. He served as a Senior Clinical Oncology Specialist for Tarceva from 2004 to 2012, and later as a Region Program Manager for the HER Family in the Southeast from 2012 to 2017. Additionally, he worked as a Senior Immunology Clinical Specialist from 2017 to 2019. His time at Genentech contributed to his expertise in oncology and immunology.
Background and Education
Adam Wohlleben studied at the State University of New York College at Oneonta from 1992 to 1996, where he completed his undergraduate education. He also attended Montville High School, laying the foundation for his academic and professional journey in the life sciences and healthcare sectors.
Career at Pfizer Pharmaceuticals
Before his roles at Genentech and Seagen, Wohlleben worked at Pfizer Pharmaceuticals as a Senior Oncology Specialist from 1999 to 2004. In this capacity, he gained valuable experience in oncology sales and account management, further solidifying his career in the pharmaceutical industry.